These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21056251)

  • 1. Editorial comment. Sex hormones and the risk of incident prostate cancer.
    Thomas JA; Bañez L; Freedland SJ
    Urology; 2010 Nov; 76(5):1040-1. PubMed ID: 21056251
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediagnostic serum hormones and the risk of prostate cancer.
    Nomura A; Heilbrun LK; Stemmermann GN; Judd HL
    Cancer Res; 1988 Jun; 48(12):3515-7. PubMed ID: 3370644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Getting over testosterone: postulating a fresh start for etiologic studies of prostate cancer.
    Carpenter WR; Robinson WR; Godley PA
    J Natl Cancer Inst; 2008 Feb; 100(3):158-9. PubMed ID: 18230791
    [No Abstract]   [Full Text] [Related]  

  • 4. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships of serum androgens and estrogens to prostate cancer risk: results from a prospective study in Finland.
    Dorgan JF; Albanes D; Virtamo J; Heinonen OP; Chandler DW; Galmarini M; McShane LM; Barrett MJ; Tangrea J; Taylor PR
    Cancer Epidemiol Biomarkers Prev; 1998 Dec; 7(12):1069-74. PubMed ID: 9865423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgenic hormones and prostate cancer risk: status and prospects.
    Gann PH
    IARC Sci Publ; 2002; 156():283-8. PubMed ID: 12484188
    [No Abstract]   [Full Text] [Related]  

  • 7. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
    Platz EA; Giovannucci E
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):237-53. PubMed ID: 15663987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case-control studies of selected hormones and prostate cancer. An epidemiologic review.
    Flanders WD
    Ala J Med Sci; 1986 Oct; 23(4):439-43. PubMed ID: 3789318
    [No Abstract]   [Full Text] [Related]  

  • 9. Circulating steroid hormones and the risk of prostate cancer.
    Severi G; Morris HA; MacInnis RJ; English DR; Tilley W; Hopper JL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):86-91. PubMed ID: 16434592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective, population-based study of androstenedione, estrogens, and prostatic cancer.
    Barrett-Connor E; Garland C; McPhillips JB; Khaw KT; Wingard DL
    Cancer Res; 1990 Jan; 50(1):169-73. PubMed ID: 2293551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer.
    Dalais FS; Meliala A; Wattanapenpaiboon N; Frydenberg M; Suter DA; Thomson WK; Wahlqvist ML
    Urology; 2004 Sep; 64(3):510-5. PubMed ID: 15351581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex steroid hormone metabolism in relation to risk of aggressive prostate cancer.
    Black A; Pinsky PF; Grubb RL; Falk RT; Hsing AW; Chu L; Meyer T; Veenstra TD; Xu X; Yu K; Ziegler RG; Brinton LA; Hoover RN; Cook MB
    Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2374-82. PubMed ID: 25178985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
    Chen C; Weiss NS; Stanczyk FZ; Lewis SK; DiTommaso D; Etzioni R; Barnett MJ; Goodman GE
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1410-6. PubMed ID: 14693730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period.
    Missmer SA; Spiegelman D; Bertone-Johnson ER; Barbieri RL; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):972-8. PubMed ID: 16702379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies.
    Eaton NE; Reeves GK; Appleby PN; Key TJ
    Br J Cancer; 1999 Jun; 80(7):930-4. PubMed ID: 10362098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Obesity and endocrine functions. Sex hormones].
    Kley HK; Zimmermann H; Krüskemper G
    Dtsch Med Wochenschr; 1981 Sep; 106(37):1163-7. PubMed ID: 6806057
    [No Abstract]   [Full Text] [Related]  

  • 18. V89L polymorphism of the 5alpha-reductase Type II gene (SRD5A2), endogenous sex hormones, and prostate cancer risk.
    Boger-Megiddo I; Weiss NS; Barnett MJ; Goodman GE; Chen C
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):286-91. PubMed ID: 18268111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.
    Yu H; Shu XO; Li BD; Dai Q; Gao YT; Jin F; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1067-73. PubMed ID: 14578144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fat protrusion of the skin and sex hormones in Klinefelter syndrome].
    Nürnberger F; Riedel-Pauls W; Gräf KJ; Hasan SH; Müller G
    Z Hautkr; 1979 Jan; 54(2):47-57. PubMed ID: 760323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.